T-cell Peripheral Lymphoma
📧 Sign up to get email alerts when something new happens for T-cell Peripheral Lymphoma.
Sign up free-
CLINICAL_TRIALS trial_result · 2020-08-18Clinical Trial Update: Phase 1 Trial of Siplizumab and Dose-Adjusted EPOCH-Rituximab in T- and NK-Cell Lymphomas [Phase 1]
Phase 1 trial evaluating siplizumab with dose-adjusted EPOCH-Rituximab in T- and NK-cell lymphomas has completed with results posted.